Yehuda Handelsman to Recombinant Fusion Proteins
This is a "connection" page, showing publications Yehuda Handelsman has written about Recombinant Fusion Proteins.
Connection Strength
0.150
-
Glycemic Efficacy, Weight Effects, and Safety of Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists. J Manag Care Spec Pharm. 2018 Sep; 24(9-a Suppl):S14-S29.
Score: 0.150
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.